Kestra Medical Technologies, Ltd. Common Stock (KMTS)
Kestra Medical Technologies, Ltd. is a medical device company focused on developing and commercializing innovative cardiac mapping and electrophysiology solutions. The company's products aim to improve the diagnosis and treatment of arrhythmias through advanced visualization and mapping technologies designed to enhance procedural efficiency and outcomes in electrophysiology procedures.
Company News
Kestra Medical Technologies reported a 52% revenue increase in Q1 FY2026, driven by rising ASSURE wearable defibrillator prescriptions. Despite strong top-line growth, the company experienced widening losses and increased operating expenses.
Kestra Medical Technologies, Ltd. (KMTS) announced the closing of its upsized initial public offering, raising approximately $202 million. The company's shares began trading on the Nasdaq Global Select Market.